While momentous, the approval of Cobenfy could also draw attention to an age-old problem in American healthcare: Will insurance barriers keep patients from getting an effective medicine?

The FDA has approved Cobenfy, a dual M1/M4 muscarinic agonist that offers a fundamentally different approach to treating ...

A medicine that sidesteps the brain's dopamine receptors to reach different targets represents a new approach to ...

The promising drug combination was discovered and tested by Karuna Therapeutics, which Bristol Myers Squibb acquired in March. Bristol Myers Squibb will sell the drug combination under the brand name ...

The FDA has approved the first treatment for schizophrenia that targets cholinergic receptors rather than dopamine receptors.

Bristol Myers Squibb received U.S. Food and Drug Administration (FDA) approval on Thursday for its groundbreaking ...

Bristol-Myers Squibb's acquisition of Karuna and FDA approval of Cobenfy signal growth potential, with focus on driving ...

Roche's oral anti-obesity candidate outperformed a similar candidate from Viking Therapeutics in terms of efficacy. Viking Therapeutics' oral anti-obesity candidate appears much easier to tolerate ...

The funding aims at supporting further advancements on the Coventry-based firms technology platform to accelerate the development of biologic therapeutics. Funding was co-led by BGF, Octopus ...

Actress Karuna Pandey, known for her role in Pushpa Impossible, shares her journey from learning Bharatnatyam and Kathak to pursuing a degree in Performing Arts. Despite the pressures of social ...

Seven jobs will be cut at Coventry University following a review into its Centre for Peace and Security. The centre contributes to work on human security, peace studies and social relations ...

Teachers' Day celebrates educators' pivotal role in shaping futures. Artists recount how their teachers profoundly impacted their lives and careers. They highlight lessons of independence ...